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Abstract
Introduction: Sedation protocols are needed for neurointensive patients. The aim of this pilot study was to describe 
sedation practice at a neurointensive care unit and to assess the feasibility and efficacy of a new sedation protocol. The 
primary outcomes were a shift from sedation-based to analgesia-based sedation and improved pain management. The 
secondary outcomes were a reduction in unplanned extubations and duration of sedation.
Methods: This was a two-phase (before-after), prospective controlled study at a university-affiliated, 14-bed 
neurointensive care unit in Denmark. The sample included patients requiring mechanical ventilation for at least 48 
hours treated with continuous sedative and analgesic infusions or both. During the observation phase the participants 
(n = 106) were sedated as usual (non-protocolized), and during the intervention phase the participants (n = 109) were 
managed according to a new sedation protocol.
Results: Our study showed a shift toward analgo-sedation, suggesting feasibility of the protocol. We found a 
significant reduction in the use of propofol (P < .001) and midazolam (P = .001) and an increase in fentanyl (P < .001) 
and remifentanil (P = .003). Patients selected for daily sedation interruption woke up faster, and estimates of pain free 
patients increased from 56.8% to 82.7% (P < .001), suggesting efficacy of the protocol. The duration of sedation and 
unplanned extubations were unchanged.
Conclusions: Our pilot study showed feasibility and partial efficacy of our protocol. Some neurointensive patients 
might not benefit from protocolized practice. We recommend an interdisciplinary effort to target patients requiring 
less sedation, as issues of oversedation and inadequate pain management still need more attention.
Trial registration: ISRCTN80999859.
Introduction
Most mechanically ventilated patients in the intensive
care unit (ICU) need sedation and analgesia to maintain
comfort, relieve anxiety, facilitate care, and adapt to ven-
tilatory support [1]. Although a variety of indications for
sedation exist, recent years have seen a general trend
toward lighter sedation for the mechanically ventilated
patient [2]. Daily sedation interruption has been used as a
way of reducing escalation of medication doses and a new
study has demonstrated the feasibility of a protocol of no
sedation [3]. Another trend has been the reversal from
sedation-analgesia to analgo-sedation, with the primary
goal of addressing pain and discomfort, and then if neces-
sary, adding sedation [4-7]. Variations in the management
of sedation, analgesia, and neuromuscular blockade have
been demonstrated internationally [2,8-12]. Protocols
have been introduced to increase consistency, and studies
have shown that sedation protocols may decrease the
duration of mechanical ventilation, the incidence of ven-
tilator-associated pneumonia (VAP), and improve the
probability of successful extubation in general ICUs [13-
15].
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Guidelines for the sustained use of sedatives and anal-
gesics have been developed for patients in the general
ICU [16], but little attention has been directed toward
sedation of patients in the neurointensive care unit
(NICU). Although neurointensive patients share many
goals with general ICU patients, some indications are
unique to the NICU population, such as maintaining ade-
quate cerebral perfusion pressure (CPP), while control-
ling intracranial pressure (ICP) and mean arterial
pressure (MAP) [17,18]. Sedation in NICU is complicated
due to many specific, and sometimes conflicting, indica-
tions. Conditions such as delirium, anxiety and pain may
all result in agitation, but need to be treated individually
[19,20]. One particular challenge is the inability to ade-
quately assess the sedation level, and to distinguish
between the indications for sedation and for pain relief,
due to the reduced level of consciousness. We suspected
that over-sedation and inadequate pain management
might be evident at our study site. The aim of the present
study was to describe sedation practice at a neurointen-
sive care unit and to assess the feasibility and efficacy of a
sedation protocol based on the principles of analgo-seda-
tion.
Material and methods
Design
The following was an interventional non-randomized
controlled single-center trial at a 14-bed NICU at a 1,082-
bed university hospital in Denmark. The study consisted
of an observational period of usual care, and an interven-
tional period using a multidisciplinary evidence-based
protocol for analgo-sedation. Usual care at our study site
consisted of non-protocolized sedation and mechanical
ventilation. We developed a 10-page sedation protocol
for the study, which was implemented during an eight-
month interim between the two study periods. The seda-
tion protocol was introduced to the participants after the
observational period to avoid contamination by prior
knowledge of the protocol. The flow-diagram from our
sedation protocol is shown in Figure 1. In order to obtain
adherence to the study, two nurses were allocated to
manage implementation of the sedation protocol
between the study periods, and facilitate data collection
throughout the study. The two nurses did not manage
sedation practice during the intervention period.
The primary outcomes were (1) a shift from sedation-
based to analgesia-based sedation (analgo-sedation),
assessed from the changes in the use of sedatives and
analgesic agents in each patient, and (2) improved pain
management, assessed daily in each patient using the
Pain Intensity scale [21]. The secondary outcomes were a
reduction in unplanned extubations and duration of con-
tinuous sedation or analgesia. Unplanned extubations
included deliberate (patient involvement) and accidental
extubations.
Participants
Participants were consecutively enrolled in the study dur-
ing two seven-month periods in January through July
2007 and April through October 2008; 106 participants
were recruited for the first study period and 109 new par-
ticipants were recruited for the second study period (215
participants recruited in total, Figure 2).
Inclusion criteria
The inclusion criteria were as follows: male and female
patients > 17 years of age admitted to NICU; patients
mechanically ventilated ≥ 48 hours; and patients receiv-
ing continuous infusions of sedatives and analgesics or
both.
Exclusion criteria
Patients excluded from the study were those transferred
intubated from other units to the NICU; patients receiv-
ing infusions of sedatives or analgesics < 48 hours;
patients intubated later than 24 hours after NICU admis-
sion; and potential organ donors or patients receiving ter-
minal care.
Intervention
The sedation protocol was developed by an interdisci-
plinary team consisting of nurses and physicians at the
study site, and the protocol was subsequently externally
evaluated by experts at other hospitals, who were asked
to assess and provide feed-back on the protocol. Concep-
tion of the protocol was inspired by the clinical practice
guideline developed by the Society of Critical Care Medi-
cine for general intensive care patients [16]. In addition to
this, the protocol was written in accordance with the
principles for analgo-sedation [4], and adjusted to meet
the specific indications for sedation in neurointensive
patients [22], for example, subarachnoid hematoma, trau-
matic brain injury, medullar injury, status epilepticus, and
neuromuscular disease. The 10-page analgo-sedation
protocol included the following general and specific rec-
ommendations, for example: Analgesics (fentanyl,
remifentanil, oxycodone) should be given before a seda-
tive; Sedatives (propofol or midazolam) should be admin-
istered only if necessary; Remifentanil should be
administered for short-term sedation only (less than
three to five days); Fentanyl (not remifentanil) should be
administered for patients with traumatic brain injury.
Data collection
Baseline characteristics at inclusion were sex, age, weight,
APACHE II (Acute Physiology and Chronic Health Evalu-
ation), SAPS II (Simplified Acute Physiology Score),Egerod et al. Critical Care 2010, 14:R71
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Figure 1 Flow-diagram for analgo-sedation protocol.
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propofol infusion  
< 3 mg/kg/h  
Increase propofol 
infusion to > 3 mg/kg/h 
Acetaminophen 1 gram x 4 p.o. or 
oxycodone/morphine i.v. prn or fentanyl 
i.v. prn (in kidney failure) 
Remifentanil infusion  
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anticipated < 1-2 days 
Increase dose of fentanyl 
infusion 
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propofol infusion 
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Assessment for pain and 
analgesia requirement  
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pentobarbital (mebumal) 
 
If intracranial hypertension, 
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confer with neurosurgeon and 
anesthetist  
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Fentanyl infusion  
< 0,200 microgram/h if 
anticipated > 1-2 days 
Increase remifentanil to max 
45 microgram/kg/h  
If Analgo-sedation > 3-5 
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midazolam bolus or 
midazolam infusion 
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restlessness, and sedation 
requirement 
Increase propofol 
infusion to 3-5 mg/kg/h 
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midazolam bolus 
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SOFA (Sequential Organ Failure Assessment), and
admission diagnosis. The study protocol included daily
registration of medication doses (continuous infusions
and boluses of propofol, midazolam, fentanyl, remifenta-
nil, morphine, and oxycodone), sedation level (Ramsay
Sedation Scale), pain level (Pain Intensity Scale), and level
of consciousness (Glasgow Coma Scale, GCS). In addi-
tion, daily sedation interruption, duration of sedation
interruption, late pneumonia, and accidental extubations
were recorded. Sedation level was assessed by nurses
once on each shift (day, evening, night) on the six-point
Ramsay Sedation Scale (RSS): agitated/restless = 1, ori-
ented/cooperative = 2, responding to commands only = 3,
brisk response to light glabellar tap = 4, sluggish response
to light glabellar tap = 5, no response = 6 [23]. The target
sedation level was RSS 2 to 3 (in patients with increased
ICP, the target was 5 to 6). Pain was estimated during
each shift in conjunction with the sedation level on the
six-point Pain Intensity scale (PI): no pain = 1, mild pain
= 2, moderate pain = 3, severe pain = 4, very severe pain =
5, worst possible pain = 6 [21]. Pain estimation was deter-
mined by alterations in vital signs (blood pressure, heart
rate, respiratory frequency) and facial expression (gri-
macing), and behavior (agitation). Interrater reliability
was calculated prior to the study by 10 paired assess-
ments (weighted kappa = 0.62, P = .04). The target pain
level was PI score 1 to 2. GCS was assessed during daily
sedation interruption, and during each shift along with
the sedation new level. Daily sedation interruption was
not routine for all patients, but had to be ordered by the
physician on rounds. The sedation protocol reads: 'The
physician on rounds determines whether a wake-up call
is appropriate (...) Daily wake-up call should be avoided in
patients with elevated ICP or other neurosurgical con-
traindications.'
Statistical analysis
Comparisons between the observational and intervention
group were performed using the Chi-Square test or
Fisher's exact test for categorical variables, the Mann-
Whitney test for non-parametric variables, and Student's
t-test for comparing the means of normally distributed
independent-samples. A P value of ≤ .05 was considered
statistically significant. The data analysis was performed
using SPSS (Statistical Package for the Social Sciences
version 17, SPSS Inc., an IBM Company Headquarters,
Chicago, Illinois).
Ethical considerations
The study was conducted in accordance with Good Clini-
cal Practice and the guidelines of the Declaration of Hel-
sinki; it was acknowledged by the Danish Data Protection
Agency (J.nr.2006-41-7419) and the Danish National
Committee on Biomedical Research Ethics (J.nr.KF01-
Figure 2 Trial profile.
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Dropout  
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2006-4507). There was no requirement of informed con-
sent because new drugs were not introduced.
Results
A total of 827 patients were admitted during the inclusion
periods, 604 were excluded, yielding 223 eligible patients.
Eight patients dropped out, while 215 (94% of the eligible
patients) completed the study (Figure 2). The baseline
characteristics in the two groups were similar (Table 1).
The main reasons for exclusion were intubation later than
24 hours after admission, terminal care, and organ dona-
tion. The reasons for dropout were intubation less than
48 hours, and organ donation.
Hospital stay, NICU stay, duration of mechanical venti-
lation, duration of sedation, and unplanned extubation
were unchanged. The relatively short hospital stay
reflects patient transfer to other facilities offering neuro-
rehabilitation. The small number of unplanned extuba-
tions does not permit evaluation with sufficient power.
NICU mortality decreased non-significantly from 30% to
24% (Table 2).
The sedation level was unchanged in the two study
groups with a mean Ramsay score at 4.38/4.41 respec-
tively (Table 3). The proportion, however, of RSS 2 to 3
(oriented and cooperative) increased from 10% to 19%
and RSS 1 (agitated) decreased from 2% to 0.5% (P  =
.035). The mean GCS during daily sedation interruption
was unchanged at 8.19/8.28 (Table 3), whereas the num-
ber of patients selected for daily awakening decreased
from 47 (44%) to 22 (20%) among the patients awakened.
Although the number of patients decreased, the fre-
quency of daily awakening among these patients
increased from 2.6 daily awakening trials to 6.7 (P = .003).
The mean duration of sedation interruption (delay before
GCS was assessed) decreased from 30 to 60 minutes to <
30 minutes (P = .001), with an increase from 48.0% to
69.1% of sessions lasting < 30 minutes (P = .001). The
pain intensity score was significantly reduced from 1.54
in the observational period to 1.24 in the intervention
period (P < .001).
The distribution of pain-level assessments is shown in
Table 4. The estimation of no pain increased from 56.8%
to 82.7% of the recordings (P < .001).
The medication pattern shifted from sedative to analge-
sic infusions. Table 5 shows a significant reduction in the
daily dose of propofol and midazolam, and a significant
increase in the daily dose of fentanyl and remifentanil.
The number of days morphine was used decreased signif-
icantly, while the use of oxycodone increased in accor-
dance with the protocol recommending a shift from
morphine to oxycodone. The use of remifentanil
increased as per protocol, but the agent was used beyond
the three to five consecutive days recommended. During
the observational period 18 cases lasted 6 to 16 days, and
during the intervention period 22 cases lasted 6 to 19
days.
Discussion
The aim of the study was to describe sedation practice at
a neurointensive care unit and to assess the feasibility and
efficacy of a sedation protocol based on the principles of
analgo-sedation. Current sedation practice at a Danish
NICU in 2007 (observation period) was non-protocolized
sedation and mechanical ventilation, using primarily con-
Table 1: Baseline characteristics at inclusion
Observational period
(n = 106)
Intervention period
(n = 109)
P Value
Male, n (%) 73 (69%) 65 (60%) .159
Female, n (%) 33 (31%) 44 (40%) .159
Age, mean years (SD) 55 (15) 52 (17) .100
Weight, mean kg (SD) 78 (14) 75 (16) .267
APACHE II, mean score (SD) 20 (4) 21 (5) .477
SAPS II, mean score (SD) 51 (10) 50 (11) .500
SOFA, mean score (SD) 8 (2) 8 (2) .707
Diagnosis, n (%) .186
SAH/ICH 50 (47%) 37 (34%)
SDH/TBI 37 (35%) 41 (38%)
Other 19 (18%) 30 (28%)
Sex and diagnosis (Chi-Square test); age, weight, APACHE II, SAPS II, SOFA (t-test); and P value ≤ .05 significant.
ICH: intracerebral hemorrhage; SAH: subarachnoid hemorrhage; SDH: subdural hematoma; TBI: traumatic brain injury. Other: Medullar lesion, 
status epilepticus, neuromuscular disease, tumors, infections.Egerod et al. Critical Care 2010, 14:R71
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tinuous infusions of propofol and midazolam for sedation
and fentanyl and morphine for analgesia. This is consis-
tent with findings from general ICUs in Denmark in 2003
[2]. The primary outcomes were a shift from sedation-
based to analgesia-based sedation, and improved pain
management. Our study showed a significant reduction
in the use of propofol and midazolam and an increase in
the use of fentanyl and remifentanil, suggesting feasibility
of our protocol. The patients selected for daily sedation
interruption woke up faster, and more patients were esti-
mated to be pain free, supporting our suspicion and sug-
gesting efficacy of our protocol. The secondary outcomes
of fewer unplanned extubations and shorter duration of
sedation were unchanged, suggesting limited efficacy of
our protocol.
The sedation level was measured by the Ramsay Seda-
tion Scale, which was chosen for pragmatic reasons. It is
the most commonly used sedation scoring system in
Denmark, where the scale is integrated with the comput-
erized Patient Data Management system at many hospi-
tals [2]. The Ramsay scale does not require patient
cooperation and is used at about 40% of Danish ICUs, as
compared to 38% in a study of North American hospitals
[2,24]. Other sedation scoring systems used in Denmark
are the Motor Activity Assessment Scale (MAAS) 15%,
the Riker Sedation-Agitation Scale (SAS) 12%, the Rich-
mond Agitation Sedation Scale (RASS) 9%, and the Cook
and Palma Scale (COOK) 7% [25]. Many of these sedation
scales have demonstrated validity and good inter-rater
reliability [26].
The mean sedation level in our study was Ramsay 4 to 5
(brisk to sluggish response), which is comparable to the
mean SAS score of 3 to 4 (difficult to rouse) found in sim-
ilar studies of neurointensive patients [21]. Although the
proportion of assessments at the target level of Ramsay 2
to 3 increased, it was unrealistic to reach this level in all
patients. One reason is that many patients were unre-
sponsive due to their neurologic condition or drug accu-
mulation. Another reason is that the protocol
recommended Ramsay 5 to 6 in patients with elevated
ICP. These issues demonstrate some of the challenges of
sedation management in neurointensive patients [27].
Many patients were sedated with remifentanil, which
should permit rapid awakening in the neurologically
Table 2: Length of stay, duration of treatment, complications, and mortality
Observational period
(n = 106)
Intervention period
(n = 109)
P Value
Hospital stay, n (mean days) SD 12 (1 to 34) 7.9 12 (2 to 42) 8.8 .861
NICU stay, n (mean days) SD 9 (1 to 28) 6.6 9 (1 to 33) 7.1 .526
Mechanical ventilation, mean 
days (range) SD
6 (1 to 24) 5.3 7 (1 to 25) 6.2 .346
Sedation, mean days (range) SD 5 (1 to 19) 3.9 5 (1 to 18) 4.0 .575
Unplanned extubation, n (%) 7 (1%) 8 (3%)
NICU mortality, n (%) 32 (30%) 25 (24%) .353
Length of stay and duration of treatment (t-test) and unplanned extubation (Chi-Square test).
Table 3: Level of sedation, consciousness, and pain (Ramsay, GCS, and PI)
Observational period
(n = 106)
Intervention period
(n = 109)
P Value
Ramsay score mean (SD) 4.38 (1.21) 4.41 (1.25) .651
GCS mean during sedation (SD) 7.49 (2.81) 7.42 (3.03) .688
GCS mean during sedation 
interruption (SD)
8.19 (2.92) 8.28 (2.79) .807
Duration of sedation 
interruption, n (%)
- mean minutes delay
47 (44%)
30 to 60
22 (20%)
<30
.001*
PI score mean (SD) 1.54 (.73) 1.24 (.61) <.001*
Ramsay Sedation Score & Glasgow Coma Score, GCS (t-test); Pain Intensity Score, PI (Mann-Whitney test);
* P value ≤ .05 significant.Egerod et al. Critical Care 2010, 14:R71
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unimpaired. Due to the ultra-short duration of action, the
protocol did not recommend bolus remifentanil [21].
Also, due to lack of clinical evidence, the protocol did not
recommend using remifentanil more than five days con-
secutively. Although the similar baseline characteristics,
length of stay, and sedation scores in the before-after
study suggest that data were recorded accurately, the
extended continuous use of remifentanil shows that
adherence to the protocol was inadequate. More studies
are needed to determine the consequences of long-term
use of remifentanil.
The duration of mechanical ventilation remained
unchanged in the two groups in our study. Studies of gen-
eral ICU patients have demonstrated significantly shorter
median duration of mechanical ventilation using a nurse-
implemented sedation protocol [13,15,28]. Our findings
may, in part, be due to the consistently low level of con-
sciousness in our population. A GCS of 3 to 8 has been
used as an indication for intubation in trauma patients
[29]. The small number of unplanned extubations may be
attributed to over-sedation or reduced level of conscious-
ness. The NICU mortality and number of unplanned
extubations in our study are comparable to general ICUs,
as were the APACHE II and SAPS II scores [15,28].
Fewer patients in the intervention period were slow to
awake, which might be ascribed to decreased use of
midazolam (long-acting sedative) and less drug accumu-
lation. Although the use of fentanyl increased, the prob-
l e m  o f  d r u g  a c c u m u l a t i o n  i s  l e s s  s e v e r e  t h a n  i n
midazolam [30]. The shift from fentanyl to remifentanil
(short acting opiate) also led to a shorter delay in awaken-
ing. The shift to analgo-sedation might explain why fewer
patients were estimated to be in pain. Fewer patients were
selected for daily awakening, but the frequency increased,
suggesting that the selection of patients was more appro-
priate in the intervention period, and was a sign of adher-
ence to the protocol. Sedation was not interrupted in
patients that required deeper sedation, but among
patients requiring less sedation, fewer were over-sedated,
even prior to awakening.
Our study had several limitations. This was a single-
center study, which means that the results may not trans-
late to other units. Due to the small population of the
country, the volume of neurointensive patients is limited,
but a multicenter study would have been a stronger
design. The choice of a before-after design was not opti-
mal, but a randomized study was not feasible at the unit
due to risk of control group contamination. The Pain
Intensity scale is inherently subjective as it depends on
the estimate of the clinician. In the future, a more accu-
rate scoring system for pain in the unresponsive patient
needs to be developed and validated. The similar GCS in
the observational and intervention periods in the study
increased the internal validity. Also, the mean GCS was
similar to other studies, thus increasing the external
validity of our findings [19]. The study design would have
been stronger if intracranial pressure, cerebral perfusion
pressure and mean arterial pressure had been recorded
on relevant patients. Finally, the extended use of remifen-
tanil suggests that the period of implementation should
have been longer, ensuring better adherence to the proto-
c o l .  W e  h a v e  s ee n  a  po s i t i v e  e f f ect  o f  t h e  p r o t oc o l  o n
management of sedation and pain, but the sample is
small, and more attention needs to be directed towards
sedation issues in the NICU population in general and
the needs of sub-groups of patients in particular.
Conclusions
This pilot study showed feasibility and partial efficacy of
our protocol. Some neurointensive patients might not
benefit from protocolized practice because the duration
of mechanical ventilation is more influenced by level of
consciousness related to underlying illness, and the ongo-
ing need for airway protection, and less influences by sed-
atives and analgesics. We recommend an
interdisciplinary effort to target patients requiring less
Table 4: Distribution of pain-level scores (PI)
Observational period Intervention period
PI-assessments Count % Count %
No pain 288 56.8 420 82.7
Mild pain 171 33.7 68 13.4
Moderate pain 44 8.7 12 2.4
S e v e r e  p a i n 20 . 451 . 0
Very severe pain 1 0.2 2 0.4
Worst possible pain 0 0.0 1 0.2
507 100.0 508 100.0
PI, pain intensityEgerod et al. Critical Care 2010, 14:R71
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sedation, as issues of over-sedation and inadequate pain
management in neurointensive patients still need more
attention.
Key messages
• Sedation protocols for neurointensive patients are
needed
• Neurointensive patients are difficult to assess for
degree of pain and sedation due to reduced level of
consciousness
• Validated instruments for assessment of pain and
sedation levels in patients unable to self-report are
needed
• The presented analgo-sedation protocol resulted in
more pain free patients and in shorter delays in daily
awakening of selected patients
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Table 5: Continuous sedative and analgesic infusions
Observational period
(n = 106, days = 553)
Intervention period
(n = 109, days = 556)
P Value
Propofol days (% of total days) 307 (56%) 283 (51%) .006*
Mean dose/day (mg) ± SD 2,592 ± 1,623 2,074 ± 1,308 < .001*
Range (mg) 550 to 7,910 510 to 7,070
Midazolam days (% of total 
days)
49 (9%) 80 (14%) .078
Mean dose/day (mg) ± SD 238 ± 152 157 ± 122 .001*
Range (mg) 3 to 485 0 to 425
Fentanyl days (% of total days) 137 (25%) 114 (21%) .171
Mean dose/day (mcg) ± SD 2,303 ± 1,606 4,919 ± 3,588 < .001*
Range (mcg) 80 to 8,000 100 to 16,000
Remifentanil days (% of total 
days)
297 (54%) 420 (76%) .281
Mean dose/day (mcg) ± SD 6,888 ± 5,373 8,233 ± 6,384 .003*
Range (mcg) 1,000 to 18,000 1,000 to 19,000
Morphine days (% of total 
days)
41 (7%) 7 (1%) .009*
Mean dose/day (mg) ± SD 16 ± 9 10 ± 0 .077
Range (mg) 7 to 40 10 to 10
Oxycodone days (% of total 
days)
67 (12%) 74 (13%) .199
Mean dose/day (mg) ± SD 25 ± 22 20 ± 14 .079
Range (mg) 5 to 100 3 to 69
Number of days (t-test), medication dose (Mann-Whitney), and * P value ≤ .05 significant. Range was calculated within limits of adequate 
sedation.Egerod et al. Critical Care 2010, 14:R71
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